Does long-term use of sibutramine (Meridia) result in continued weight loss in short-term responders?
Stevenson
J H
JH
University of Connecticut School of Medicine and Saint Francis Hospital and Medical Center Hartford, USA.
Trojian
T
T
Jackson
E A
EA
D000293:Adolescent; D000328:Adult; D000368:Aged; D001067:Appetite Depressants / Q000008:administration & dosage*; D015992:Body Mass Index; D003503:Cyclobutanes / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine